FEATURED ARTICLES
Unlocking Gentler, Cost-Efficient TIL Therapy For Cold Tumors
CuraCell Head of Clinical Operations Torbjörn Ström discusses, in the context of CC-38 and CytoPLY-derived tumor-infiltrating lymphocytes (TILs), the utility of named-patient experience, dosing and preconditioning, and T-cell therapy capabilities in cold solid tumors.
-
![female doctor shakes hands with her young female patient-GettyImages-2123113270]( "Navigating The New EU Pharmaceutical Legislation: Key Implications For Pediatric Drug Development")
Navigating The New EU Pharmaceutical Legislation: Key Implications For Pediatric Drug DevelopmentUCB’s Senior Development Strategy Lead Pediatrics Martine Dehlinger-Kremer, Ph.D., discusses updates to the new EU Pharma legislation and how they impact pediatric drug development, including earlier pediatric investigational plans .
-
![IND clock]( "Beyond The IND Clock: What Operation TrialBlazer Gets Right — And Where It Stalls (Part 1)")
Beyond The IND Clock: What Operation TrialBlazer Gets Right — And Where It Stalls (Part 1)The FDA's Operation TrailBlazer includes a proposal to speed up IND review and approval. But will it work? Kimberly Chew and Odette Hauke identify where the initiative succeeds and where the structural gaps begin.
-
![IND clock (1)]( "Beyond The IND Clock: The Legal Architecture Of QRIs And What Industry Must Say Before July 22 (Part 2)")
Beyond The IND Clock: The Legal Architecture Of QRIs And What Industry Must Say Before July 22 (Part 2)The FDA's Operation TrailBlazer includes a proposal to speed up IND review and approval. But Kimberly Chew and Odette Hauke say its legal architecture is unresolved and reveals compliance issues that are hard to ignore.
SERVICES & PRODUCTS
Proof-of-concept provides a critical bridge between Phase 1 and Phase 2 trials, making an experienced CRO partner vital to achieving optimal outcomes for early-phase clinical research.
Ensure accurate, compliant, and impactful documentation with Altasciences' experienced medical writers and regulatory experts.
Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.
At DVCR, our Central Laboratory Services are built for multi-site studies, combining customizable kits, next-day results and real-time shipment monitoring to keep every site aligned and on schedule. Backed by dedicated client teams, a comprehensive Central Lab Manual and rapid-response testing, we deliver the flexibility and speed your studies require.
Your trusted partner for decentralized post-marketing surveillance clinical trials and real-world evidence collection. Point-of-need accessibility. Proven compliance.
Why Work With AutoCruitment?
AutoCruitment is the ultimate patient recruitment solution for clinical trials. We specialize in identifying, enrolling, and supporting the most qualified patients for clinical trials through a sophisticated screening process that aligns directly with your study’s protocols.